KOSDAQ · Healthcare · ₩178B
₩2,515+1.62%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 3.5% · as of 26.10.27
Among 34 바이오 peers
Quarterly Revenue Growth
“이번 분기 해외 판매망이 신제품 확장의 발판이 됐어요.”
In the company's words · 2026 2분기 filing